Chira, E. C., McMillen, T. S., Wang, S., Haw, A., O’Brien, K. D., Wight, T. N., & Chait, A. (2007). Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice.

Chira, Ebele C., Timothy S. McMillen, Shari Wang, Antonio Haw, Kevin D. O’Brien, Thomas N. Wight, i Alan Chait. Tesaglitazar, a Dual Peroxisome Proliferator-activated Receptor Alpha/gamma Agonist, Reduces Atherosclerosis in Female Low Density Lipoprotein Receptor Deficient Mice. 2007.

Chira, Ebele C., et al. Tesaglitazar, a Dual Peroxisome Proliferator-activated Receptor Alpha/gamma Agonist, Reduces Atherosclerosis in Female Low Density Lipoprotein Receptor Deficient Mice. 2007.